insights_auto
Why is AVH up 6.02%?
Dive Deeperchevron_right
AVH:ASX
AVITA Medical Inc
A$3.52
arrow_upward
+6.02%(+0.20) 1D
Oct 2, 5:10:22 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVH...
Open
A$3.46
High
A$3.53
Low
A$3.46
Mkt. cap
553.98M
Avg. vol.
400.35K
Volume
500.04K
52-wk high
A$3.53
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
Open
A$3.46
High
A$3.53
Low
A$3.46
Mkt. cap
553.98M
Avg. vol.
400.35K
Volume
500.04K
52-wk high
A$3.53
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
The Motley Fool
·
3 hours ago
The S&P 500 Is Not Enough: My 3-Stock Starter Portfolio for New Investors
U.S. Global Investors
·
1 day ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
TradingView
·
4 hours ago
Energy sector outperforms S&P 500 in Q3 as oil prices rise
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com